Source comparison
IGF-1 LR3 Cycle Length: Protocol Comparison
Cycle design determines whether you observe reproducible anabolic signaling or progressive receptor desensitization. The following comparison shows four common cycle structures and their biological trade-offs. Short Cycle (2 weeks on, 2 weeks off) 14 days Days
This comparison does not assign a generated winner or score.
- Cycle design determines whether you observe reproducible anabolic signaling or progressive receptor desensitization. The following comparison shows four common cycle structures and their biological trade-offs.
- Short Cycle (2 weeks on, 2 weeks off)
- 14 days
- Days 5–14
- Minimal. Stops before significant downregulation
- Excellent. Maintains receptor sensitivity across 4+ cycles
- Best for multi-cycle research designs requiring consistent response magnitude across multiple iterations. Sacrifices cumulative exposure for repeatability.
- Standard Cycle (3 weeks on, 3 weeks off)
- 21 days
- Days 7–21
- Low. Exits just as downregulation begins
- Very good. Preserves 80–85% receptor density between cycles
- Optimal for most research applications. Balances cumulative anabolic exposure with receptor preservation. Gold standard for controlled studies.
- Extended Cycle (4 weeks on, 4 weeks off)
- 28 days
- Days 7–24
- Moderate. Enters downregulation curve but exits before severe adaptation
- Good. Requires strict washout adherence to maintain efficacy
- Acceptable when research timeline justifies maximum single-cycle exposure. Last 7 days show diminishing marginal returns.
- Prolonged Cycle (6 weeks on, 6 weeks off)
- 42 days
- 42 days minimum (8 weeks preferred)
- Days 7–28
- High. Significant receptor downregulation by day 35+
- Poor. Second cycle produces 30–40% weaker response even with 6-week washout
- Not recommended except in single-cycle terminal studies. Extends washout requirements and compromises future cycle efficacy.